£67 million upgrade underway at GSK's Montrose facility
WEBJan 15, 2024 · GSK is planning to invest £200m in its UK manufacturing operations over the next two years. The pharmaceutical giant is currently in the middle of a multi-year £67m upgrade to its Montrose site, which includes a new …
Pharma giant GSK's new £44m facility in Montrose ... - The National
WEBAug 16, 2017 · NICOLA Sturgeon has opened a new £44 million facility for pharma giant GSK (GlaxoSmithKline) in Angus which will produce 400 million vaccines every year. GSK’s aluminium salts unit in Montrose makes ingredients for vaccines for various illnesses, including tetanus, pneumonia and whooping cough.
GlaxoSmithKline opens new $56.6M vaccines plant in Scotland
WEBAug 15, 2017 · GlaxoSmithKline opened its new $56.6 million vaccines plant in Montrose, Scotland, that will manufacture sterile aluminum salts and includes a microbiology lab.
New £44m facility at GSK Montrose - gov.scot - The Scottish …
WEBAug 15, 2017 · First Minister Nicola Sturgeon welcomed GSK’s (GlaxoSmithKline) commitment to Montrose as she opened their new £44 million aluminium salts facility. The site produces ingredients for vaccines for illnesses including tetanus, pneumonia and whooping cough.
GSK invests in Montrose - gov.scot - The Scottish Government
WEBOct 22, 2018 · GSK’s £54 million new state-of-the-art production building in Montrose has been opened by First Minister Nicola Sturgeon. Active pharmaceutical ingredients (APIs) for use in GSK’s Ellipta respiratory inhalers will be produced in the building which is the second multi-million investment in the Montrose site over the last two years.
GSK invests in Montrose - Life Sciences Scotland
WEBOct 22, 2018 · GSK’s £54 million new state-of-the-art production building in Montrose has been opened by First Minister Nicola Sturgeon. Active pharmaceutical ingredients (APIs) for use in GSK’s Ellipta respiratory inhalers will be produced in the building and it is the second multi-million investment on the Montrose site over the last two years.
GSK affirms its long-term commitment to manufacturing in Scotland
WEBBuilt at a cost of £44M, the new facility at GSK’s site at Montrose in north-east Scotland will manufacture sterile aluminium salts which are compounds that boost the human body’s response to vaccines and supply them to GSK’s vaccine factories around the world.
GSK opens new aluminium salts facility in Scotland
WEBAug 16, 2017 · GlaxoSmithKline has officially opened a new £44 million aluminium salts facility in Montrose, Scotland, which is set to supply ingredients for around 400 million vaccines a year.
GSK opens £44M aluminum salts facility in Scotland
WEBAug 17, 2017 · Scottish First Minister Nicola Sturgeon has cut the ribbon on GlaxoSmithKline plc’s newest aluminum salts manufacturing plant, located in Montrose, Scotland. The site will supply the British drugmaker’s vaccine facilities in …
Nicola Sturgeon officially opens GlaxoSmithKline's £44m Montrose …
WEBAug 15, 2017 · Nicola Sturgeon has officially opened GlaxoSmithKline's new £44 million aluminium salts facility at its site in Montrose. The new facility includes a microbiology laboratory, will manufacture sterile aluminium salts – compounds which boost the human body’s response to vaccines.
- Some results have been removed
Skip to content